`
`
`
`
`
`
`
`
`Paper 42
` Entered: September 27, 2017
`
`Trials@uspto.gov
`571-272-7822
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`
`QUALICAPS CO. LTD.,
`Patent Owner.
`____________
`
`Case IPR2017-00203
`Patent 6,649,180
`____________
`
`
`
`Before CHRISTOPHER M. KAISER, JEFFREY W. ABRAHAM, and
`ELIZABETH M. ROESEL, Administrative Patent Judges.
`
`Per Curiam
`
`
`
`
`AMENDED SCHEDULING ORDER
`37 C.F.R. § 42.5
`
`
`
`
`
`
`
`Case IPR2017-00203
`Patent 6,649,180
`
`
`The Oral Hearing in this case (Due Date 7) was originally scheduled
`
`for December 6, 2017. Paper 11, 8. Due to a scheduling conflict, the Oral
`
`Hearing is hereby rescheduled for January 25, 2018. The due date for a
`
`Request for Oral Argument is reset to December 6, 2017. All other Due
`
`Dates in the original Scheduling Order (Paper 11) remain the same.
`
`
`FOR PETITIONER:
`
`Mitchell Stockwell
`Clay Holloway
`Miranda Rogers
`KILPATRICK TOWNSEND & STOCKTON LLP
`mstockwell@kilpatricktownsend.com
`cholloway@kilpatricktownsend.com
`mrogers@kilpatricktownsend.com
`
`
`FOR PATENT OWNER:
`
`Jessica Parezo
`Andrea Reister
`Scott Kamholz
`COVINGTON & BURLING LLP
`jparezo@cov.com
`areister@cov.com
`skamholz@cov.com
`
`Maryanne Armstrong
`Lynde Herzbach
`BIRCH, STEWART, KOLASCH & BIRCH, LLP
`maa@bskb.com
`lynde.herzbach@bskb.com
`
`2
`
`
`
`